Previous close | 1.1700 |
Open | 1.1600 |
Bid | 1.0600 x 100 |
Ask | 1.1600 x 100 |
Day's range | 1.0800 - 1.1675 |
52-week range | 0.7560 - 6.7000 |
Volume | |
Avg. volume | 385,637 |
Market cap | 29.93M |
Beta (5Y monthly) | 1.11 |
PE ratio (TTM) | N/A |
EPS (TTM) | -10.1600 |
Earnings date | 13 May 2024 - 17 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 27.80 |
Biora Therapeutics, Inc. (NASDAQ:BIOR) Q4 2023 Earnings Call Transcript March 26, 2024 Biora Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Biora Therapeutics Fourth Quarter 2023 Financial Results Call. At this time, all participants are […]
Q4 2023 Biora Therapeutics Inc Earnings Call
All performance targets achieved in single-ascending dose (SAD) cohorts of BT-600 clinical trial Results demonstrated targeted drug delivery and absorption in the colon, with 3-4 times lower drug levels in blood Remainder of BT-600 clinical trial progressing well and on schedule Management will host conference call and webcast today at 4:30 PM Eastern / 1:30 PM Pacific SAN DIEGO, March 26, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining t